
Sergio Ochatt
Related Authors
Asha Vijayan
Amrita Vishwa Vidyapeetham
Jon R Sayers
The University of Sheffield
Jeffrey Townsend
Yale University
Jean-Jacques Hublin
Max Planck Institute for Evolutionary Anthropology
Elif Karlık
Istanbul University
Timothy Morton
Rice University
Darwin H . Pangaribuan
The University Of Lampung
Romit Seth
North Carolina State University
Prof Manjit S Kang
Kansas State University
Carlos Manuel Faísca
University of Coimbra
Uploads
Papers by Sergio Ochatt
India. This species is a promising natural source of bioactive compounds including galanthamine (GAL), an
anti-Alzheimer drug. In vitro regeneration in the Amaryllidaceae is often challenging. This study assessed the
use of meta-Topolin (mT) on in vitro regeneration of C. malabaricum. Shoot explants were cultured on Murashige and Skoog (MS) medium supplemented with 0.5, 2.5, 5.0, 7.5 and 10.0 mM mT for six weeks, whereby
7.5 mM mT resulted in the maximum multiplication of adventitious shoots, much higher than the control.
The biochemical accumulation of eleven different phenolic acids was quantified by UHPLC-MS/MS analysis,
and it appeared that mT-treated cultures exhibited the highest concentration of phenolic acids. In particular,
increased concentrations of gallic acid, protocatechuic acid, syringic acid, p-hydroxybenzoic acid, salicylic
acid and vanillic acid were detected compared to the control. mT (2.5 and 5.0 mM) produced the maximum
amount of chlorogenic acid, ferulic acid, p-coumaric acid and sinapic acid. However, an increased content of
caffeic acid was produced on PGR-free medium. These findings highlight the beneficial effect and validate
the rising importance of mT for in vitro regeneration studies. This study will serve as a potential protocol to
conserve and restore the medically important C. malabaricum.
pharmacological leads. Plant-derived biomolecules have historically proven their value as a source of therapeutic drugs and
hold an important potential for the identifcation and characterization of novel drug leads. Many diferent alkaloids possessing a broad range of pharmacological activities have been isolated from plants belonging to the Amaryllidaceae family.
Galanthamine (GAL) is a selective, reversible and an Amaryllidaceae-derived acetylcholinesterase inhibitor used for the
treatment of Alzheimer’s disease (AD) and other neurological diseases. Naturally, the bioavailability of Amaryllidaceae
alkaloids including GAL is low. Due to the signifcantly increased demand of GAL by the pharmaceutical industries and
the inadequate availability of natural resources, in vitro culture ofers an alternative approach for its sustainable production.
Thus, diferent biotechnological tools can optimize the in vitro GAL biosynthesis for treating AD, such as manipulation
of plant growth regulators, photoperiod, elicitors, and bioreactors systems, besides being an environmentally sustainable
approach, which protects the native biodiversity in a circular bioeconomy context. In the present review, we highlight the
biosynthesis of GAL by plant in vitro systems including its mode of action. This article should also provide a starting point
in the scaling-up of the biotechnological production of this valuable alkaloid.
India. This species is a promising natural source of bioactive compounds including galanthamine (GAL), an
anti-Alzheimer drug. In vitro regeneration in the Amaryllidaceae is often challenging. This study assessed the
use of meta-Topolin (mT) on in vitro regeneration of C. malabaricum. Shoot explants were cultured on Murashige and Skoog (MS) medium supplemented with 0.5, 2.5, 5.0, 7.5 and 10.0 mM mT for six weeks, whereby
7.5 mM mT resulted in the maximum multiplication of adventitious shoots, much higher than the control.
The biochemical accumulation of eleven different phenolic acids was quantified by UHPLC-MS/MS analysis,
and it appeared that mT-treated cultures exhibited the highest concentration of phenolic acids. In particular,
increased concentrations of gallic acid, protocatechuic acid, syringic acid, p-hydroxybenzoic acid, salicylic
acid and vanillic acid were detected compared to the control. mT (2.5 and 5.0 mM) produced the maximum
amount of chlorogenic acid, ferulic acid, p-coumaric acid and sinapic acid. However, an increased content of
caffeic acid was produced on PGR-free medium. These findings highlight the beneficial effect and validate
the rising importance of mT for in vitro regeneration studies. This study will serve as a potential protocol to
conserve and restore the medically important C. malabaricum.
pharmacological leads. Plant-derived biomolecules have historically proven their value as a source of therapeutic drugs and
hold an important potential for the identifcation and characterization of novel drug leads. Many diferent alkaloids possessing a broad range of pharmacological activities have been isolated from plants belonging to the Amaryllidaceae family.
Galanthamine (GAL) is a selective, reversible and an Amaryllidaceae-derived acetylcholinesterase inhibitor used for the
treatment of Alzheimer’s disease (AD) and other neurological diseases. Naturally, the bioavailability of Amaryllidaceae
alkaloids including GAL is low. Due to the signifcantly increased demand of GAL by the pharmaceutical industries and
the inadequate availability of natural resources, in vitro culture ofers an alternative approach for its sustainable production.
Thus, diferent biotechnological tools can optimize the in vitro GAL biosynthesis for treating AD, such as manipulation
of plant growth regulators, photoperiod, elicitors, and bioreactors systems, besides being an environmentally sustainable
approach, which protects the native biodiversity in a circular bioeconomy context. In the present review, we highlight the
biosynthesis of GAL by plant in vitro systems including its mode of action. This article should also provide a starting point
in the scaling-up of the biotechnological production of this valuable alkaloid.
This Special Issue will include research on all aspects of the development of biotechnology-based approaches for the increased biomass production and better understanding of the production and synthesis of secondary metabolites by in vitro cell and tissue cultures of medicinal plants. One or two authoritative reviews, Original Research Articles, Research Notes and Protocol papers will be considered. Submissions are welcome up to October 31st 2021, and should be prepared in compliance with the journal guidelines. Publication is expected early in 2022.
This Special Issue will be co-edited by (alphabetically) A.R. Alan (Turkey), A. Bhattacharya (India), C. Hano (France), K.V. Kiselev (Russia), P.L. Marconi (Argentina), W.C. Otoni (Brazil), S.Y. Park (Republic of Korea), K. Tang (China), P.J. Weathers (USA), and S. Ochatt (France) as editor-in-chief.
KEYWORDS
Agrobacterium, biochemical analyses, callus, cell suspensions, CRISPR/Cas9, elicitors, flow cytometry, fluxomics, gene expression, gene transfer, genetic stability, genome editing, genomics, HPLC, medicinal plants, metabolomics, microscopy, molecular analyses, organogenesis, proteomics, protoplasts, RAPD, somaclonal variation, somatic embryogenesis, specialized metabolites, transcriptomics